ITC Treatment Centers

 

Community Analytics has partnered with Prometheus, Inc. to learn more about the treatment of mRCC and metastatic melanoma, in an effort to develop the best and most appropriate outreach and educational programs for treating physicians.

Frequently Asked Questions

 

What is the goal for this study?


Prometheus is continually looking for ways to improve treatment for patients with metastatic melanoma and metastatic kidney cancer. To this end, Prometheus has commissioned this research study with the following goals:

  • Profile centers across the US who are involved in treatment of patients with metastatic melanoma and kidney cancer
  • Gather data about current practices and treatments used for metastatic melanoma and kidney cancer including the use of IL-2

 

What is Community Analytics' role in this project? 


Prometheus has partnered with Community Analytics to:

  • Collect data from ITC centers across the US
  • Analyze and report the results of the study to Prometheus